First-in-man study: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +)) |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
A '''first-in-man study''' is a [[clinical trial]] where a medical procedure, previously developed and assessed through ''[[in vitro]]'' or [[animal testing]], or through mathematical modeling is tested on [[human]] subjects for the first time. | A '''first-in-man study''' is a [[clinical trial]] where a medical procedure, previously developed and assessed through ''[[in vitro]]'' or [[animal testing]], or through mathematical modeling is tested on [[human]] subjects for the first time. | ||
| Line 17: | Line 17: | ||
<br> | <br> | ||
[[Category:Experimental design]] | [[Category:Experimental design]] | ||
Latest revision as of 02:43, 9 August 2012
A first-in-man study is a clinical trial where a medical procedure, previously developed and assessed through in vitro or animal testing, or through mathematical modeling is tested on human subjects for the first time.
Such studies present particular risks to the human subjects as was signally the case in the disastrous TGN1412 trial in 2006. Consequently, there are ethical issues as to whether such trials should be performed on healthy volunteers, who have nothing to gain beyond a fee, or on patients who have a chance of enjoying a health benefit.
Bibliography
- Working Party on Statistical Issues in First-in-Man Studies (2007). "Statistical issues in first-in-man studies". Journal of the Royal Statistical Society. 170A: 517–579.